Impact of platelets on major thrombosis in patients with a normal white blood cell count in essential thrombocythemia

Veronika Buxhofer‐Ausch(Johannes Kepler University of Linz), Heinz Gisslinger(Medical University of Vienna), Dominik Wolf‎(Universität Innsbruck), Siegfried Sormann(Medical University of Graz), Bettina Gisslinger(Medical University of Vienna), Wolfgang Schimetta(Johannes Kepler University of Linz), Sonja Heibl(Klinikum Wels-Grieskirchen), Jürgen Thiele, Reinhard Ruckser(Donauspital), Maria Theresa Krauth(Medical University of Vienna), Ernst Forjan
European Journal Of Haematology
September 25, 2020
10.1111/ejh.13516
Cited by 16

Related Papers

Development and validation of an International Prognostic Score of thrombosis in World Health Organization–essential thrombocythemia (IPSET-thrombosis)
|Blood|2012|596
Survival and Disease Progression in Essential Thrombocythemia Are Significantly Influenced by Accurate Morphologic Diagnosis: An International Study
|Journal of Clinical Oncology|2011|540
Erythropoietin Treatment of Anemia Associated with Multiple Myeloma
|New England Journal of Medicine|1990|450
Risk factors for arterial and venous thrombosis in WHO-defined essential thrombocythemia: an international study of 891 patients
|Blood|2011|448
Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study
|The Lancet Haematology|2020|351